Logo

Tepnel to Provide DNA-Extraction Services for AstraZeneca

May 04, 2006

NEW YORK, May 4 (GenomeWeb News) - Tepnel Life Sciences said today that it has signed a global agreement to provide DNA-extraction services for AstraZeneca.

 

Tepnel said it has been appointed a "preferred supplier" to AstraZeneca under the terms of the agreement, and will have the "opportunity to compete for further business."

 

Financial terms of the agreement were not disclosed.

Breaking News
The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.